| pubmed-article:18625521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C1269683 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C0245561 | lld:lifeskim |
| pubmed-article:18625521 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18625521 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18625521 | pubmed:dateCreated | 2009-1-26 | lld:pubmed |
| pubmed-article:18625521 | pubmed:abstractText | Using data from a relapse prevention study of duloxetine treatment for adults with major depressive disorder (MDD), we examined demographic- and illness-related variables to identify factors that may predict relapse of MDD. | lld:pubmed |
| pubmed-article:18625521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18625521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18625521 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18625521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18625521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18625521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18625521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18625521 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:18625521 | pubmed:issn | 1573-2517 | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:FavaMaurizioM | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:WiltseCurtisC | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:WalkerDanielD | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:PerahiaDavidD | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:BrechtStephan... | lld:pubmed |
| pubmed-article:18625521 | pubmed:author | pubmed-author:ChenAndrewA | lld:pubmed |
| pubmed-article:18625521 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18625521 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:18625521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18625521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18625521 | pubmed:pagination | 263-71 | lld:pubmed |
| pubmed-article:18625521 | pubmed:dateRevised | 2009-9-28 | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:meshHeading | pubmed-meshheading:18625521... | lld:pubmed |
| pubmed-article:18625521 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18625521 | pubmed:articleTitle | Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder. | lld:pubmed |
| pubmed-article:18625521 | pubmed:affiliation | Massachusetts General Hospital, Boston, MA 02114, United States. MFava@Partners.org | lld:pubmed |
| pubmed-article:18625521 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18625521 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18625521 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
